Journal of Hypertension and Cardiology

Aims and Scope

Open Access Pub launches the Open Peer-Reviewed Journal-"Journal of Hypertension and Cardiology” The journal aims to cover the latest outstanding developments in the prevention, management, treatment of cardiovascular diseases.
 

Journal of Hypertension and Cardiology is a peer-reviewed, open-access journal that focuses on the latest research and developments in the fields of hypertension and cardiology. The journal aims to provide a platform for researchers, clinicians, and academicians to publish high-quality original research, review articles, case reports, and clinical studies related to hypertension and cardiology.
 

The scope of the journal includes, but is not limited to, the following topics:

• Hypertension: This section covers research on the epidemiology, etiology, pathophysiology, diagnosis, and management of hypertension. It includes studies on blood pressure regulation, hypertension-related complications, and novel therapeutic approaches.
• Cardiac Diseases: This section encompasses research on various cardiac diseases, including coronary artery disease, heart failure, arrhythmias, valvular heart disease, and congenital heart defects. It also includes studies on cardiac imaging, biomarkers, and novel treatment strategies.
• Cardiovascular Risk Factors: This section focuses on the identification and management of cardiovascular risk factors such as obesity, diabetes, dyslipidemia, smoking, and sedentary lifestyle. It includes research on the impact of these risk factors on cardiovascular health and the development of preventive measures.
• Hypertension and Cardiology in Special Populations: This section covers research on hypertension and cardiac diseases in special populations such as children, adolescents, pregnant women, and elderly individuals. It includes studies on the unique challenges and management strategies for these populations.
• Hypertension and Cardiology Research Methodology: This section includes articles on research methodologies, clinical trials, epidemiological studies, and statistical analyses related to hypertension and cardiology research.
• Emerging Technologies and Innovations: This section focuses on the latest technological advancements, diagnostic tools, and treatment modalities in the fields of hypertension and cardiology.
• Application of Artificial Intelligence (AI): By integrating AI with cardiology, we aim to advance the precision and effectiveness of diagnosing and treating Cardiovascular disease ultimately improving patient outcomes and quality of care.

Contributions from the following research areas are invited but not limited to the following branches:

• Diabetes
• Myocarditis
• Aneurysm
• Blood pressure
• Cholesterol
• Tachycardia
• Congestive heart failure
• Atrial Fibrillation
• Hemophilia
• Stroke
• Atherosclerosis
• Cardiac arrest
• Cardiomyopathy
• Bradycardia
• Myocardial Infarction
• Coronary Artery Disease
• Metabolism
• Pulmonary Hypertension
• Internal Medicine
• Metabolic Syndrome
• Radiology
• Thrombosis
• Drugs
• Endocarditis
• Obesity
• Pacemaker
• Endocrinology
• Von Willebrand Disease
• Intervention
• Heart Rate
• Pathophysiology
• Cardiology
• Arteriosclerosis
• Body Mass Index
• Diastolic Pressure
• Ejection Fraction
• Hyperthyroidism
• Stem cells
• Antiphospholipid Syndrome
• Takotsubo Cardiomyopathy
• Congenital heart disease
• Pharmacology
• Acute coronary syndrome
• Raynaud Syndrome
• Cardiac Output
• Dilated Cardiomyopathy
• Factor V Leiden
• Hypertensive Crisis
• Coronary heart disease
• Hypertension Treatment
• Ischemic heart disease
• Vascular disease
• Molecular biology
• Cerebrovascular disease
• Coagulopathy
• Diastole
• Disseminated Intravascular Coagulation
• Echocardiography
• Hemophilia A